| (19) |
 |
|
(11) |
EP 2 166 020 A8 |
| (12) |
CORRECTED EUROPEAN PATENT APPLICATION |
|
published in accordance with Art. 153(4) EPC |
| (15) |
Correction information: |
|
Corrected version no 1 (W1 A1) |
| (48) |
Corrigendum issued on: |
|
19.05.2010 Bulletin 2010/20 |
| (43) |
Date of publication: |
|
24.03.2010 Bulletin 2010/12 |
| (22) |
Date of filing: 27.06.2008 |
|
| (51) |
International Patent Classification (IPC):
|
| (86) |
International application number: |
|
PCT/JP2008/061732 |
| (87) |
International publication number: |
|
WO 2009/001928 (31.12.2008 Gazette 2009/01) |
|
| (84) |
Designated Contracting States: |
|
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL
PT RO SE SI SK TR |
| (30) |
Priority: |
28.06.2007 JP 2007170550
|
| (71) |
Applicant: Asubio Pharma Co., Ltd. |
|
Minato-ku
Tokyo 107-8541 (JP) |
|
| (72) |
Inventors: |
|
- OKAMOTO, Atsushi
Mishima-gun
Osaka 618-8503 (JP)
- MAGOTA, Koji
Ohra-gun
Gunma 370-0503 (JP)
- HAYASHI, Yujiro
Ohra-gun
Gunma 370-0503 (JP)
|
| (74) |
Representative: Wachenfeld, Joachim |
|
Vossius & Partner
Siebertstrasse 4
81675 München
81675 München (DE) |
|
| |
|
| (54) |
PEPTIDE HAVING HYPOTENSIVE ACTIVITY |
(57) The present invention provides a novel peptide having a physiological activity. Because
of having a hypotensive activity, this novel peptide is useful in treating a disease
caused by hypertension. Also, an antibody to the novel peptide is provided.